Please login to the form below

Not currently logged in
Email:
Password:

Isis

This page shows the latest Isis news and features for those working in and with pharma, biotech and healthcare.

Biogen buys into Ionis' nusinersen after positive phase III trial

Biogen buys into Ionis' nusinersen after positive phase III trial

The trial has now been halted and all placebo patients have been offered the option to swap over to treatment with the active drug (also known as ISIS-SMNRx), which is ... A second phase III trial called CHERISH is also ongoing and is due to generate

Latest news

More from news
Approximately 8 fully matching, plus 25 partially matching documents found.

Latest Intelligence

  • Pharma deals in August 2015 Pharma deals in August 2015

    Building on the existing antisense relationship that was forged through its original deal with Isis [for 5 cancer targets] signed in December 2012 AstraZeneca invested further with an upfront fee of ... Exclusive licence. 90. Isis. AZ. Addition to Dec

  • Pharma deals in May 2015 Pharma deals in May 2015

    245. Isis/ Bayer. Licence agreement. Anticoagulant ISIS FXIRx for prevention of thrombosis in P2.

  • Deal Watch table for January 2015 Deal Watch table for January 2015

    Strategic collaboration. 1, 000. Isis/ Janssen. Antisense drugs to treat autoimmune disorders of the GI tract - local and oral therapies (3 programmes).

  • Pharma deals during January 2015 Pharma deals during January 2015

    A $35m payment went in an upfront to Isis as part of its $835m headline deal for a collaboration to discover and develop antisense drugs in autoimmune disorders in the GI

  • Pharma deals during November 2014 Pharma deals during November 2014

    AZ also announced a strategic alliance with ISIS Pharmaceuticals building on an existing collaboration between the companies, in the area of antisense oligonucleotide-based therapeutics and RNA biology.

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics